New Biomedical Interface Materials
New Biomedical Interface Materials
批准号:
7267689
负责人:
ROGER E MARCHANT
金额:
$32.64万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-03-01 至 2009-08-31
关键词:
ActinsAcuteAddressAdhesionsAdhesivesAffectAffinityAminesAnticoagulantsBindingBiocompatible MaterialsBiologicalBiomimetic MaterialsBiomimeticsBloodBlood PlateletsCell AdhesionCell surfaceCellsCoagulation ProcessComplement ActivationConditionConfocal MicroscopyDextransEndothelial CellsExtracellular MatrixFamily suidaeFibronectinsFlow CytometryFocal AdhesionsGlycocalyxGlycoproteinsGrowthHeparinHumanImageImmune responseIn VitroInfectionIntegrin BindingLabelLeadLigandsMaltoseMeasurementMeasuresMethodsMicroscopicMicroscopyModelingMolecular WeightOligosaccharidesOpticsPeptidesPlacementPlasma ProteinsPlatelet ActivationPolymersPropertyProteinsProteoglycanRGD (sequence)RadiolabeledRangeResearchResearch PersonnelResistanceShunt DeviceStress FibersSurfaceSystemTechniquesTestingThrombosisTimeVitronectin ReceptorsWound Healingbaseclinically relevantdensitydesigndextranheparin proteoglycanimprovedinterfacialmigrationnanoscaleprogramsprotein expressionradiotracerresearch studyresponseshear stresssurfactant
中文摘要
描述(由申请人提供):
目前的生物材料面临着众所周知的问题,包括血栓形成、伤口过度愈合和感染。生物材料的表面或界面是决定宿主反应的最重要因素之一。这些研究集中于新型仿生界面材料,旨在改善宿主对生物材料的反应,并基于一个中心假设,即控制低聚糖和/或细胞黏附肽在生物材料上的空间放置将促进程序化的生物反应,使非特异性相互作用最小化,并增强细胞-表面的选择性相互作用和剪切稳定的表面内皮化。拟议的研究将通过两个操作范例--‘细胞表面糖基化’和‘细胞外基质’,为仿生设计提供指导,并将具体研究集中在:(1)仿生材料,模仿糖萼的非粘附性和抗凝功能,旨在改善血液相容性;和(2)仿生材料,在ECM中模拟粘附性糖蛋白,旨在促进剪切稳定的内皮化。仿生材料在一系列临床相关的生物材料上进行表面诱导组装,由表面活性聚合物和侧链寡糖、多肽和疏水配体组成。低聚糖包括糖树状大分子和瓶刷结构,它们将提供密集的糖萼状界面。类ECM仿生材料包含高亲和力的整合素结合肽和肝素蛋白多糖结合肽,通过光谱和显微技术进行表征,包括辅助定量表面配体密度和表面组装的纳米成像方法。体外血液相容性将通过光谱、显微镜和标记测量在明确定义的流动条件下进行确定。内皮细胞研究将包括使用共聚焦显微镜对肌动蛋白应力纤维和焦点黏附蛋白进行剪切相关分析。血液相容性也将使用已建立的猪动静脉分流模型来确定。从这些研究中,我们将确定仿生界面的改变与血液相容性和剪切稳定性内皮化相关的机制。
英文摘要
DESCRIPTION (provided by applicant):
Current biomaterials suffer from well-known problems including thrombosis, excessive wound healing, and infection. The surface, or interface, of a biomaterial is one of the most important factors that determine these host responses. The proposed studies focus on new biomimetic interface materials designed to improve host responses to biomaterials, and are based on the central hypothesis that controlled spatial placement of oligosaccharides and/or cell adhesion peptides on a biomaterial will facilitate programmed biological responses that minimize non-specific interactions, and enhance selective cell-surface interaction and shear stable surface endothelialization. Proposed research will be focused through two operational paradigms, 'cell surface glycocalyx' and 'extracellular matrix' (ECM), that provide guidance in biomimetic designs and focus specific research on: (1) Biomimetic materials that mimic the non-adhesive properties and anticoagulant function of a glycocalyx, designed to improve blood compatibility; and (2) biomimetic materials that mimic adhesive glycoproteins in the ECM designed to facilitate shear stable endothelialization. The biomimetic materials undergo surface-induced assembly on a range of clinically relevant biomaterials, and consist of surfactant polymers with pendant oligosaccharides, peptides, and hydrophobic ligands. The oligosaccharides include glycodendrimers and bottle-brush constructs that will provide a dense glycocalyx-like interface. ECM-like biomimetic materials incorporate high affinity integrin binding and heparin proteoglycan binding peptides, characterized by spectroscopic and microscopic techniques including methods to assist in the quantification of surface ligand densities and nanoscale imaging of surface assemblies. In vitro blood compatibility will be determined from spectroscopic, microscopic, and labeling measurements under well defined flow conditions. Endothelial cell studies will include shear-dependent analysis of actin stress fibers and focal adhesion proteins using confocal microscopy. Blood compatibility also will be determined using a well-established porcine a-v shunt model. From these studies, we shall determine the mechanisms by which alterations in the biomimetic interface correlates to blood compatibility and shear stable endothelialization.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/bm050611p
发表时间:
2006-03
期刊:
Biomacromolecules
影响因子:
6.2
作者:
[Junmin Zhu;R. Marchant]
通讯作者:
Junmin Zhu;R. Marchant
Acute Swine Model for Assessing Biocompatibility of Biomedical Interface Materials.
用于评估生物医学界面材料生物相容性的急性猪模型。
DOI:
10.1089/ten.tec.2017.0310
发表时间:
2018
期刊:
Tissue engineering. Part C, Methods
影响因子:
--
作者:
[Takaseya,Tohru, Fumoto,Hideyuki, Zhu,Junmin, Shiose,Akira, Kobayashi,Mariko, Fujiki,Masako, Arakawa,Yoko, Dessoffy,Raymond, KramerJr,LarryD, Fukamachi,Kiyotaka]
通讯作者:
Fukamachi,Kiyotaka
DOI:
10.1016/j.biomaterials.2009.08.004
发表时间:
2009-10
期刊:
BIOMATERIALS
影响因子:
14
作者:
[Beamish, Jeffrey A., Geyer, Leah C., Haq-Siddiqi, Nada A., Kottke-Marchant, Kandice, Marchant, Roger E.]
通讯作者:
Marchant, Roger E.
DOI:
10.1016/j.biomaterials.2009.04.038
发表时间:
2009-09
期刊:
BIOMATERIALS
影响因子:
14
作者:
[Beamish, Jeffrey A., Fu, Alexander Y., Choi, Ae-jin, Haq, Nada A., Kottke-Marchant, Kandice, Marchant, Roger E.]
通讯作者:
Marchant, Roger E.
DOI:
10.1163/156856209x426439
发表时间:
2009
期刊:
Journal of biomaterials science. Polymer edition
影响因子:
--
作者:
[Wang S, Gupta AS, Sagnella S, Barendt PM, Kottke-Marchant K, Marchant RE]
通讯作者:
Marchant RE
共 13 条
Vascularization of polymeric tissue beds
-
批准号:7828505
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:ROGER E MARCHANT
-
依托单位:
Vascularization of polymeric tissue beds
-
批准号:7935299
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7575728
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7372150
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7799769
-
项目类别:
-
资助金额:$52.48万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6729145
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6623483
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6466235
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6872197
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:2750625
-
项目类别:
-
资助金额:$19.89万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:2372966
-
项目类别:
-
资助金额:$19.06万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:6043981
-
项目类别:
-
资助金额:$25.72万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:2028365
-
项目类别:
-
资助金额:$22.2万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
New Biomedical Interface Materials
-
批准号:6948212
-
项目类别:
-
资助金额:$34.43万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:2219478
-
项目类别:
-
资助金额:$21.49万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
New Biomedical Interface Materials
-
批准号:7115826
-
项目类别:
-
资助金额:$33.62万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:6536919
-
项目类别:
-
资助金额:$28.54万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:6638275
-
项目类别:
-
资助金额:$24.82万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:2219477
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:3471873
-
项目类别:
-
资助金额:$11.48万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
海外基金